Effect of hydroxyurea treatment on renal function parameters: Results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia

Pediatric Blood and Cancer

Volumn 59, Issue 4, 2012, Pages 668-674

  Alvarez, Ofelia ^a   Miller, Scott T ^b   Wang, Winfred C ^c   Luo, Zhaoyu ^d   Mccarville, M Beth ^c   Schwartz, George J ^e   Thompson, Bruce ^d   Howard, Thomas ^f   Iyer, Rathi V ^g   Rana, Sohail R ^h   Rogers, Zora R ⁱ   Sarnaik, Sharada A ^j   Thornburg, Courtney D ^k   Ware, Russell E ^l  

^a UNIVERSITY OF MIAMI   (United States)

^b KINGS COUNTY HOSPITAL CENTER   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d Clinical Trials & Surveys Corp   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^h HOWARD UNIVERSITY   (United States)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Glomerular filtration rate; Hydroxyurea; Kidney function; Urine osmolality

Indexed keywords

CREATININE; CYSTATIN C; HYDROXYUREA; PENTETATE TECHNETIUM TC 99M; PLACEBO;

ARTICLE; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; ECHOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFANT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SERUM OSMOLALITY; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; ULTRAFILTRATION; URINALYSIS; URINE OSMOLALITY;

ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; CREATININE; CYSTATIN C; DOUBLE-BLIND METHOD; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYDROXYUREA; INFANT; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; OSMOLAR CONCENTRATION; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M PENTETATE;

EID: 84864917063     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24100     Document Type: Article

References (44)

1. Scheinman JI. Sickle cell disease and the kidney. Nat Clin Pract Nephrol 2009; 5: 78-88.
2. Becker AM. Sickle cell nephropathy: Challenging the conventional wisdom. Pediatr Nephrol 2011; 26: 2099-2109.
3. Sharpe CC, Thein SL. Sickle cell nephropathy-a practical approach. Br J Haematol 2011; 155: 287-297.
4. McPherson Yee M, Jabbar SF, Osunkwo I, et al. Chronic kidney disease and albuminuria in children with sickle cell disease. Clin J Am Soc Nephrol 2011; 6: 2628-2633.
5. Wong WY, Elliott-Mills D, Powars D. Renal failure in sickle cell anemia. Hematol Oncol Clin North Am 1996; 10: 1321-1331.
6. Jayabose S, Tugal O, Sandoval C, et al. Clinical and hematological effects of hydroxyurea in children with sickle cell anemia. J Pediatr 1996; 129: 559-565.
7. Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999; 94: 1550-1554.
8. Wang WC, Wynn LW, Rogers ZR, et al. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr 2001; 139: 790-796.
9. Thornburg CD, Nixon N, Burgett S, et al. A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatr Blood Cancer 2008; 52: 609-615.
10. Thompson BW, Miller ST, Rogers ZR, et al. The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design. Pediatr Blood Cancer 2010; 54: 250-255.
11. Thornburg CD, Rogers ZR, Jeng MR, et al. Adherence to study medication and visits: Data from the BABY HUG trial. Pediatr Blood Cancer 2010; 54: 260-264.
12. Ware RE, Rees RC, Sarnaik SA, et al. Renal function in infants with sickle cell anemia: Baseline data from the BABY HUG trial. J Pediatr 2010; 156: 66-70.
13. Newman DJ, Cystatin C. Ann Clin Biochem 2002; 39: 89-104.
14. Miller ST, Wang WC, Iyer R, et al. Urine concentrating ability in infants with sickle cell disease: Baseline data from the phase III trial of hydroxyurea (BABY HUG). Pediatr Blood Cancer 2010; 54: 265-268.
15. Schwartz GJ, Haycock GB, Edelmann CM Jr, et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263.
16. Schwartz GJ, Muñoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629-637.
17. Furth SL, Cole SR, Moxey-Mims M, et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 2006; 1: 1006-1015.
18. Zappitelli M, Parvex P, Joseph L, et al. Derivation and validation of cystatin C-based prediction equations for GFR in children. Am J Kidney Dis 2006; 48: 221-230.
19. Filler G, Lepage N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 2003; 18: 981-985.
20. Fleming JS, Zivanovic MA, Blake GM, et al. Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nuclear Med Comm 2004; 25: 759-769.
21. Piepsz A, Colarinha P, Gordon I, et al. Guidelines for glomerular filtration rate determination in children. Eur J Nucl Med 2001; 28: BP31-BP36.
22. 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci 1984; 66: 613-619.
23. 99m DTPA serum clearance for estimating glomerular filtration rate in children with cancer. Pharmacotherapy 1993; 13: 10-16.
24. Mc Carville MB, Luo Z, Huang X, et al. Abdominal ultrasound with scintigraphic and clinical correlates in very young children with sickle cell anemia: Baseline data from BABY HUG Trial. AJR Am J Roentgenol 2011; 196: 1399-1404.
25. Dinkel E, Ertel M, Dittrich M, et al. Kidney size in childhood. Sonographical growth charts for kidney length and volume. Pediatr Radiol 1985; 15: 38-43.
26. Walker TM, Serjeant GR. Increased renal reflectivity in sickle cell disease: Prevalence and characteristics. Clin Radiol 1995; 50: 566-569.
27. Wang W, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle cell-anaemia: A multicentre, randomised, controlled trial (BABY HUG). Lancet 2011; 377: 1663-1672.
28. Randers E, Krue S, Erlandsen EJ, et al. Reference interval for serum cystatin C in children. Clin Chem 1999; 45: 1856-1858.
29. Boer DP, de Rijke YB, Hop WC, et al. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol 2010; 25: 2107-2113.
30. Finney H, Newman DJ, Thakkar H, et al. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 2000; 82: 71-75.
31. Fischback M, Graff V, Terzic J, et al. Impact of age on reference values for serum concentration of cystatin C in children. Pediatr Nephrol 2002; 17: 104-106.
32. 51Cr-ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging 2006; 33: 1477-1482.
33. 51Cr-EDTA clearance. Clin Physiol Funct Imaging 2010; 30: 169-174.
34. Bröchner-Mortensen J, Haahr J, Christoffersen J. A simplified method for accurate assessment of glomerular filtration rate in children. Scand J Clin Lab Invest 1974; 33: 133-143.
35. Bokenkamp A, Domanetzki M, Zinck R, et al. Cystatin C-a new marker of glomerular filtration rate in children independent of height and age. Pediatrics 1998; 101: 875-881.
36. Alvarez O, Zilleruelo G, Wright D, et al. Serum cystatin C levels in children with sickle cell disease. Pediatr Nephrol 2006; 21: 533-537.
37. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-1421.
38. Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol 2000; 63: 205-211.
39. Rosenbaum DM, Korngold E, Littlewood Teele R. Sonographic assessment of renal length in normal children. AJR 1984; 142: 467-469.
40. Marild S, Jodal U, Jonasson G, et al. Reference values for renal concentrating capacity in children by the desmopressin test. Pediatr Nephrol 1992; 6: 254-257.
41. Fotopoulos A, Bokharhli JA, Tsiouris S, et al. Comparison of six radionuclidic and non-radionuclidic methods for the assessment of glomerular filtration rate in patients with chronic renal failure. Hell J Nucl Med 2006; 9: 133-140.
42. Field JJ, Austin PF, An P, et al. Enuresis is a common and persistent problem among children and young adults with sickle cell anemia. Urology 2008; 72: 81-84.
43. Aygun B, Mortier N, Smeltzer MP, et al. Glomerular hyperfiltration and microalbuminuria in children with sickle cell anemia. Pediatr Nephrol 2011; 26: 11285-11290.
44. Alvarez O, Montane B, Lopez G, et al. Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr Blood Cancer 2006; 47: 71-76.